Internal Radionuclide Therapy of Primary Osteosarcoma in Dogs, Using153Sm-Ethylene-diamino-tetramethylene-phosphonate (EDTMP)

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages

  Aas, Magne ^a   Moe, Lars ^b   Gamlem, Hans ^c   Skretting, Arne ^a   Ottesen, Nina ^b   Bruland, øyvind S ^a  

^a Norwegian Radimn Hospital   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c Central Veterinary Laboratory   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LEXIDRONAM SAMARIUM SM 153;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANIMAL MODEL; ANIMAL TISSUE; BONE PAIN; CANCER INHIBITION; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DOG; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; METASTASIS; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; THROMBOCYTE COUNT;

ANIMALS; BONE NEOPLASMS; BRACHYTHERAPY; DOGS; FEMALE; MALE; NEOPLASM METASTASIS; OSTEOSARCOMA; PHOSPHONIC ACIDS; RADIOTHERAPY DOSAGE; SAMARIUM;

EID: 0032694511     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brodey, R. S. The use of naturally occurring cancer in domestic animals for research into human cancer. General considerations and a review of canine skeletal osteosarcoma. Yale J. Biol. Med., 52: 345-361, 1979.
2. Withrow, S. J., Powers, B. E., Straw, R. C., and Wilkins, R. M. Comparative aspects of osteosarcoma. Dogs vs. man. Clin. Orthop., 270: 159-167, 1991.
3. Brodey, R. S., and Abt, D. A. Results of surgical treatment in 65 dogs with osteosarcoma. J. Am. Vet. Med. Assoc., 168: 1032-1035, 1976.
4. Spodnick, G. J., Berg, J., Rand, W. M., Schelling, S. H., Couto, G., Harvey, H. J., Henderson. R. A., MacEwen, G., Mauldin, N., McCaw, D. L., Moore, A. S., Morrison, W., Norris, A. M., O'Bradovich, J., O'Keefe, D. A., Page, R., Ruslander, D., Klausner, J., Straw, R., Thompson, J. P., and Withrow, S. J. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J. Am. Vet. Med. Assoc., 200: 995-999, 1992.
5. Bergman, P. J., MacEwen, E. G., Kurzman, I. D., Henry, C. J., Hammer, A. S., Knapp, D. W., Hale, A., Kruth, S. A., Klein, M. K., Klausner, J., Norris, A. M., McCaw, D., Straw, R. C., and Withrow, S. J. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J. Vet. Intern. Med., 10: 76-81, 1996.
6. LaRue, S. M., and Withrow, S. J. Tumors of the skeletal system. In: S. J. Withrow and E. G. MacEwen (eds.), Clinical Veterinary Oncology, pp. 234-252. Philadelphia, PA: J. B. Lippincott, 1989.
7. Straw, R. C., Withrow, S. J., Richter, S. L., Powers, B. E., Klein, M. K., Postorino, N. C., LaRue, S. M., Ogilvie, G. K., Vail, D. M., Morrison, W. B., McGee, M., and Dickinson, K. Amputation and cisptatin for treatment of canine osteosarcoma. J. Vet. Intem. Med., 5: 205-210, 1991.
8. McEntee, M. C., Page, R. L., Novotney, C. A., and Thrall, D. E. Palliative radiotherapy for canine appendicular osteosarcoma. Vet. Radiol. Ultrasound, 30: 367-370, 1993.
9. Thrall, D. E., Withrow, S. J., Powers, B. E., Straw, R. C., Page, R. L., Heidner, G. L., Richardson, D. C., Bissonnette, K. W., Betts, C. W., DeYoung, D. J., Wrigley, R. H., Sim, D. A. Richter, S. L. LaRue, S. M. and Gillette, E. L. Radiotherapy prior to cortical allograft limb sparing in dogs with osteosarcoma: a dose response assay. Int. J. Rad. Oncol. Biol. Phys., 18: 1351-1357, 1990.
10. Lattimer, J. C., Corwin, L. A., Jr., Stapleton, J., Volkert, W. A., Ehrhardt, G. J., Ketring, A. R., Anderson, S. K., Simon, J., and Goeckeler, W. F. Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP. J. Nucl. Med., 31: 1316-1325, 1990.
11. Bruland, Ø. S., Skretting, A., Solheim, Ø. P., and Aas, M. Targeted radiotherapy of osteosarcoma using 153Sm-EDTMP. A new promising approach. Acta Oncol., 35: 381-384, 1996.
12. Pool, R. R. Tumors of bones and cartilage. In: J. E. Moulton (ed.), Tumors in Domestic Animals, 3rd ed., pp. 157-230. Berkley, CA: University of California Press, 1990.
13. Skretting, A., Bruland, Ø. S., and Aas, M. Absorbed dose estimation by combined use of CT information and whole body scanning with a dual head gamma camera in patients with osteosarcoma treated with 153Sm-EDTMP. In: H. Bergmann, A. Koiss, and H. Sinzinger (eds.), Radioactive Isotopes in Clinical Medicine and Research. Proc. of the 22nd International Badgastein Symposium, pp. 383-386. Basel, Switzerland: Birkhäiuser Verlag, 1997.
14. Bieling, P., Rehan, N., Winkler, P., Helmke, K., Maas, R., Fuchs, N., Bielack, S., Heise, U., Jürgens, H., Treuner, J., Romanowski, R., Exner, U., Katz, R., and Winkler, K. Tumor size and prognosis in aggressively treated osteosarcoma. J. Clin. Oncol., 14: 848-858, 1996.
15. Moe, L., Boysen, M., Lønaas, L., Gamlem, H., Aas, M., and Bruland, Ø. S. Maxillectomy and targeted radionuclide therapy with 153Sm-EDTMP in a recurrent canine osteosarcoma. J. Small Anim. Pract., 37: 241-246, 1996.